Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

January 1, 2005; Volume 46,Issue 1 suppl

Clinical Practice of Molecular Radiotherapy - Steven M. Larson and Eric P. Krenning, Guest Editors

Clinical Practice of Molecular Radiotherapy

  • You have access
    A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy
    Steven M. Larson and Eric P. Krenning
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 1S-3S;
  • You have access
    Radiobiologic Principles in Radionuclide Therapy
    Amin I. Kassis and S. James Adelstein
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 4S-12S;
  • You have access
    Combination Radionuclide Therapy Using 177Lu- and 90Y-Labeled Somatostatin Analogs
    Marion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. Krenning
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
  • You have access
    Dosimetry of Internal Emitters
    George Sgouros
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 18S-27S;
  • You have access
    The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma
    Richard J. Robbins and Martin J. Schlumberger
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 28S-37S;
  • You have access
    Bone-Seeking Radionuclides For Therapy
    Val J. Lewington
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 38S-47S;
  • You have access
    Radiosynovectomy in Rheumatology, Orthopedics, and Hemophilia
    Peter Schneider, Jamshid Farahati and Christoph Reiners
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 48S-54S;
  • You have access
    MIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic Use
    Farzana D. Pashankar, M. Sue O’Dorisio and Yusuf Menda
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 55S-61S;
  • You have access
    Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs
    Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
  • You have access
    Candidates for Peptide Receptor Radiotherapy Today and in the Future
    Jean Claude Reubi, Helmut R. Mäcke and Eric P. Krenning
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 67S-75S;
  • You have access
    Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
    Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
  • You have access
    Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with 90Y-DOTA0,Tyr3-Octreotide and 177Lu-DOTA0, Tyr3-Octreotate
    Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
  • You have access
    Practical Dosimetry of Peptide Receptor Radionuclide Therapy with 90Y-Labeled Somatostatin Analogs
    Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
  • You have access
    Patient-Specific Dosimetry in Predicting Renal Toxicity with 90Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship
    Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
  • You have access
    Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma
    Jaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. Krenning
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
  • You have access
    Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies
    Robert M. Sharkey and David M. Goldenberg
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 115S-127S;
  • You have access
    Tositumomab and 131I Therapy in Non-Hodgkin’s Lymphoma
    Richard L. Wahl
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 128S-140S;
  • You have access
    Current Status of Therapy of Solid Tumors
    Yuliya S. Jhanwar and Chaitanya Divgi
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 141S-150S;
  • You have access
    Current Status of Therapy of Solid Tumors: Brain Tumor Therapy
    Michael R. Zalutsky
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 151S-156S;
  • You have access
    Antibody-Based Targeted Radiation to Pediatric Tumors
    Shakeel Modak and Nai-Kong V. Cheung
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 157S-163S;
  • You have access
    The Promise of Immuno-PET in Radioimmunotherapy
    Iris Verel, Gerard W.M. Visser and Guus A. van Dongen
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 164S-171S;
  • You have access
    68Ga-Labeled Peptides in Tumor Imaging
    Helmut R. Maecke, Michael Hofmann and Uwe Haberkorn
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 172S-178S;
  • You have access
    Radiotargeted Gene Therapy
    Donald J. Buchsbaum, Tandra R. Chaudhuri and Kurt R. Zinn
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 179S-186S;
  • You have access
    Radiation Sensitizers: A Selective Review of Molecules Targeting DNA and non-DNA Targets
    Larry K. Kvols
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 187S-190S;
  • You have access
    Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides
    Leo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van Hagen
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
  • You have access
    The Promise of Targeted α-Particle Therapy
    Deborah A. Mulford, David A. Scheinberg and Joseph G. Jurcic
    Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 199S-204S;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 46 (1 suppl)
Journal of Nuclear Medicine
Vol. 46, Issue 1 suppl
January 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Clinical Practice of Molecular Radiotherapy
  • Most Cited
  • Most Read
Loading
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA
  • Fibroblast Activation Protein–Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire